Skip to main content
. 2019 Oct 11;14(10):e0222885. doi: 10.1371/journal.pone.0222885

Fig 1. Tumoral response.

Fig 1

66-year-old patient with T2N2 (Stage IIIA) left upper lobe squamous cell carcinoma. At baseline (a), tumor SUVmax was 12 g/ml, MTV 13 cc and TLG 89 g. After 2 cycles of carboplatin-paclitaxel (b), SUVmax was 8.2 g/ml (ΔSUVmax = -33%), MTV 2.4 cc (ΔMTV = -82%) and TLG 11.3 g (ΔTLG = -87%). After 45 months, the patient was still alive and showed no sign of recurrence.